Watson Acquires Andrx Despite OAI Hold Status
This article was originally published in The Pink Sheet Daily
Executive Summary
The $1.9 bil. acquisition will create the third largest generic pharmaceutical company in the U.S, Watson said March 13.
You may also be interested in...
Watson Integration Of Andrx Underway With 66 Combined ANDAs Pending
With acquisition of Andrx finalized, Watson now has three business divisions: Brand, Generic and Anda distribution.
Watson Integration Of Andrx Underway With 66 Combined ANDAs Pending
With acquisition of Andrx finalized, Watson now has three business divisions: Brand, Generic and Anda distribution.
Watson Looks To Counter Generic Pressures Through Products With High Barrier To Entry
Drug maker says it is on track to recruit a generic division president by the end of September.